← Back to work
Works cited by this work
300 works
Work: Lipid nanoparticle–based mRNA platforms for mucosal HIV vaccines: formulation advances, immune mechanisms, and translational pathways
The Benefits and Safety of Monoclonal Antibodies: Implications for Cancer Immunotherapy
Shuguang Zhang, Wen‐Ying Chen, Jihong Zhou +5
Review article20257 citationsABIAn analysis of reported cases of hemophagocytic lymphohistiocytosis (HLH) after COVID-19 vaccination
Hanqi Zhang, Buzi Cao, Qingtai Cao +3
Review article20234 citationsABILipid nanoparticles for mRNA delivery
Xucheng Hou, Tal Zaks, Róbert Langer +1
Review article20213 citationsABIHuman IgG and IgA responses to COVID-19 mRNA vaccines
Adam V. Wisnewski, Julian Campillo Luna, Carrie A. Redlich
Article20213 citationsABIMacrophage-targeted nanomedicine for chronic diseases immunotherapy
Yuejia Song, Yaqian Huang, Fang Zhou +2
Article20213 citationsABIInnate immune mechanisms of mRNA vaccines
Rein Verbeke, Michael J. Hogan, Karin Loré +1
Review article20223 citationsABISweet syndrome induced by SARS-CoV-2 vaccines: A systematic review of patient-report studies
Yilai Jia, Boyang Fu, Liping Dong +1
Review article20233 citationsABIRecent Advances in Lipid Nanoparticles and Their Safety Concerns for mRNA Delivery
Jialiang Wang, Yaopeng Ding, K. Chul Chong +7
Review article20243 citationsABIChitosan and Its Derivatives for Application in Mucoadhesive Drug Delivery Systems
Twana Mohammed M. Ways, Wing Man Lau, Vitaliy V. Khutoryanskiy
Review article20182 citationsABIThe effect of surface charge on oral absorption of polymeric nanoparticles
Xiao‐Jiao Du, Jilong Wang, Shoaib Iqbal +5
Article20182 citationsABIMucoadhesive versus mucopenetrating nanoparticles for oral delivery of insulin
Hongbo Cheng, Zhixiang Cui, Shuang Guo +3
Article20212 citationsABIImmunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics
Yeji Lee, Michaela Jeong, Jeongeun Park +2
Review article20232 citationsABI